Tag Archives: panel

RESI Panel Announcement: Explore Houston’s Innovation Drive in The Future Is Now

7 Apr

By Lucy Parkinson, Director of Research, LSN

Houston is on a roll in life science technology. In 2015, the TMCx Accelerator ran its debut class of new healthcare companies; 2016 has already seen the arrival of JLABS@TMC, and AT&T Foundry will open in Houston soon. These facilities will collectively support dozens of new healthcare inventions, fostering a diverse ecosystem of early stage life science companies in Houston. This RESI panel, The Future Is Now, will cover these new developments and explain why Houston’s moment for has come.

Moderated by Nicole Fisher, Founder & CEO, HHR Strategies, the panel will feature:

This unique session will explore how Houston has become a health innovation hub that attracts major strategic firms to open facilities for entrepreneurs. The participants will also describe the innovation that’s happening at their new facilities in Houston, how they’re supporting new technologies that are coming out of Texas Medical Center’s instutitions, and what kinds of innovators they’re looking to work with.

If you’d like to be there in person, it’s not too late to sign up to join RESI@TMCx.

RESI-Houston-2016_600

Tags: , , , , ,

RESI Panel Announcement: Family Offices

31 Mar

By Lucy Parkinson, Director of Research, LSN

Family offices often catch the interest of entrepreneurs due to the possibility of committed, long-term capital from investors who look to the long view regarding their investment decisions.  Family offices may also have unique investment motivations that relate to the family’s particular expertise and history.  With a reputation for being deep-pocketed and flexible investors, life science CEOs are often interested in meeting with family office investors, and this panel will allow the RESI@TMCx audience to learn directly from family office investment staff about how they invest, what they look for in a life science opportunity, and how to find alignment with their needs.

Moderated by Colin Widen, CEO, Boston Innovation Capital, the panelists are:

If you’re interested in listening to this panel live at RESI, you can register for RESI@TMCx now.

RESI-Houston-2016_600

Tags: , , , , ,

RESI Panel Announcement: Healthcare System Partners

31 Mar

By Shaoyu Chang, MD, MPH, Senior Research Manager, LSN

Shaoyu 10*10

The RESI team is pleased to debut a new panel on Healthcare System Partners at RESI@TMCx on April 11. In an article titled “Innovation as Discipline, Not Fad,” the New England Journal of Medicine called on healthcare organizations to embrace innovations and serve as the training ground to test their medical benefits, technical feasibility, and business viability. Many healthcare systems are doing just that. This panel will reveal the changing role healthcare organizations are playing in fostering innovation.

Moderated by Rebecca Kaul, Chief Innovation Officer, MD Anderson, this session will feature:

From innovation centers to investment vehicles, healthcare organizations have become critical partners for entrepreneurs. Whether you are considering generating user experience, conducting pilot studies, or receiving technical guidance, the value of face-to-face meetings with these institutions is unfathomable. At the heart of the world’s largest medical center, this panel will help entrepreneurs navigate complex healthcare systems and bring their companies to the next milestone.

Registering for the RESI Conference will give you the opportunity to listen to this panel live, connect with relevant investors and network with like-minded entrepreneurs.

RESI-Houston-2016_600

Tags: , , , , , ,

RESI@TMCx Panel Announcement: Diagnostic Investors

24 Mar

By Cole Bunn, Research Analyst, LSN

cole-wp

The diagnostics space encompasses a very wide range of technologies targeting indications across the board, and is arguably the most difficult sector, under the life science umbrella, to successfully navigate. Not only do these entrepreneurs have to first identify the correct capital providers and strategic partners to make their technologies a commercial reality, like everyone else, but piquing the interests of those entities may be considerably more difficult. Oftentimes, clearly articulating the value proposition of your diagnostic product/service is a little trickier than that of a more traditional therapeutic or medical device, and the go-to-market strategy for these technologies will usually be more highly scrutinized.

Moderated by John Walter, CEO & President, Alliance for Cancer Gene Therapy Foundation, this session will feature:

Given the complex strategic landscape diagnostics often face, along with the importance of the having the correct strategy in place, the value of guidance and feedback from experienced diagnostic investors can’t be overstated. This diverse set of panelists, representing a variety of different funds and organizations, will give the audience firsthand perspectives to help position their companies for success.

Registering for the RESI Conference will give you the opportunity to listen to this panel live, connect with relevant investors and network with like-minded entrepreneurs.

Tags: , , , , , , ,

RESI@TMCx Panel: Medical Device Investors Share Their Strategies

24 Mar

By Lucy Parkinson, Director of Research, LSN

Medtech innovation is one of the focuses of Texas Medical Center’s innovation programs, with TMCx focusing its startup acceleration program on medical devices and healthcare IT. RESI@TMCx will provide a venue for investors to meet with innovative medical device startups from Texas and beyond, and this panel session will explore what it takes to get a new device product funded and commercialized.

Moderated by Angela Shah, Editor, Xconomy, the panelists are:

The panelists will share their experience and insight on the medical device sector, including what areas of medical technology are of peak interest right now, what factors they examine when performing diligence on a medical device company, and what opportunities they see for the future of device innovation. If you’d like to hear from these experienced investors and from our expert moderator, you can register for RESI now.

Tags: , , , , , ,

RESI@TMCx Panel Announcement: Incubators, Accelerators & New Models

17 Mar

By Lucy Parkinson, Director of Research, LSN

With the explosion of activity in early stage life sciences in the last few years, many new programs have been formed to support the youngest new biotech, medtech and healthcare IT companies in developing their products and making first steps toward commercialization.

This RESI panel will highlight five programs that provide vital resources at the earliest stage, including support, work space, mentoring, business education, and investment. The panelists will talk about how they select companies, how they help entrepreneurs turn scientific ideas into commercial success stories, and what makes each of their programs unique.

Moderated by Atul Varadhachary, Managing Partner, Fannin Innovation Studio, this session will feature:

Tags: , , , , , ,

RESI@TMCx Panel Announcement: Early Stage Therapeutic Investors

10 Mar

By Lucy Parkinson, Director of Research, LSN

Early stage therapeutics companies have a long road ahead to reach the marketplace, and will require significant investment along their way. The level of risk involved at this stage deters some investors, and much has been written about the pull-back of many venture capital firms from this phase of investment. At RESI, a panel of 5 investors who are highly experienced in investing in early stage therapeutic development will discuss how they pick winning scientfic teams and support their portfolio companies through the challenges of the development process.

Moderated by Lisa Rhoads, Managing Director, Easton Capital, the panel will feature:

This panel will give fundraising entrepreneurs a firsthand look at the strategies used by early stage therapeutic investors to assess companies at the earliest, riskiest stage of development, and will help the audience to position their companies as an attractive investment opportunity.

By registering for RESI@TMCx, you’ll be able to listen to the early stage therapeutic panel live in person, and also experience numerous opportunities to expand your network in the life sciences and to learn more about the fundraising process.

RESI-Houston-2016_600

Tags: , , , , , , , ,

← Older Entries
Newer Entries →